Publications that are related to Sykdomspulsen.

Publications about the Sykdomspulsen system/infrastructure

White, R. A. et al. (2021). attrib: Attributable Burden of Disease. R package version 2021.9.20. URL:

Publications that include data and/or results from the Sykdomspulsen implementation at FHI

Arnesen, T. M. et al. (2021). Tuberkulose i Norge 2019 og 2020 - med behandlingsresultater for 2018 og 2019. Norwegian Institute of Public Health. URL:

Bragstad, K. et al. (2021). Norway National Influenza Centre: Influenza Virological and Epidemiological season report prepared for the WHO Consultation on the Composition of Influenza Virus Vaccines for the Southern Hemisphere 2022. Norwegian Institute of Public Health. URL:

Engebretsen, S. et al. (2021). “Regional probabilistic situational awareness and forecasting of COVID-19”. In: medRxiv. DOI: 10.1101/2021.10.25.21265166.

Herrador, B. G. et al. (2021). “Heavy weather events, water quality and gastroenteritis in Norway”. In: One Health 13, p. 100297. DOI: 10.1016/j.onehlt.2021.100297.

Influenza-Department (2021). Influenza season in Norway 2020-21. Norwegian Institute of Public Health. URL:

Vestergaard, L. S. et al. (2020). “Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020”. In: Eurosurveillance 25.26. DOI: 10.2807/

Amato, E. et al. (2019). “Increase of scabies infestations, Norway, 2006 to 2018”. In: Eurosurveillance 24.23. DOI:

Arnesen, T. M. et al. (2019). Tuberkulose i Norge 2018 - med behandlingsresultater for 2017. Norwegian Institute of Public Health. URL:

Benedetti, G. et al. (2019). “Identifying exceptional malaria occurrences in the absence of historical data in South Sudan: a method validation”. In: Public Health Action 9.3, pp. 90–95. DOI: 10.5588/pha.19.0002.

Nielsen, J. et al. (2019). “European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?” In: Clinical Microbiology and Infection 25.10, pp. 1266–1276. DOI: 10.1016/j.cmi.2019.02.011.

Arnesen, T. M. et al. (2018). Tuberkulose i Norge 2017 - med behandlingsresultater for 2016. Norwegian Institute of Public Health. URL:

Wisløff, T. et al. (2018). “Feasibility of reaching world health organization targets for hepatitis C and the cost-effectiveness of alternative strategies”. In: Journal of Viral Hepatitis 25.9, pp. 1066–1077. DOI: 10.1111/jvh.12904.

Wisløff, T. et al. (2018). “Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway”. In: PharmacoEconomics 36.5, pp. 591–601. DOI: 10.1007/s40273-017-0604-3.

Arnesen, T. M. et al. (2017). Tuberkulose i Norge 2016 - med behandlingsresultater for 2015. Arsrapport. Delrapport 5 av Smittesomme sykdommer i Norge 2016. Norwegian Institute of Public Health. URL:—med-behandlingsresultater-for-2015.pdf.

Meijerink, H. et al. (2017). “Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030”. In: BMC Infectious Diseases 17.1. DOI: 10.1186/s12879-017-2631-2.

Vestergaard, L. S. et al. (2017). “Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017”. In: Eurosurveillance 22.14. DOI: 10.2807/

White, R. A. et al. (2014). “Projected Treatment Capacity Needs in Sierra Leone”. In: PLoS Currents. DOI: 10.1371/currents.outbreaks.3c3477556808e44cf41d2511b21dc29f.


If you see mistakes or want to suggest changes, please create an issue on the source repository.


Text and figures are licensed under Creative Commons Attribution CC BY 4.0. Source code is available at, unless otherwise noted. The figures that have been reused from other sources don't fall under this license and can be recognized by a note in their caption: "Figure from ...".